Citation: Daj. Moore et al., REVERSAL OF ABNORMALITIES OF NEUTROPHIL ADHESION MOLECULE EXPRESSION IN HIV-INFECTION FOLLOWING PROTEASE INHIBITOR THERAPY, AIDS, 12(15), 1998, pp. 2083-2084
Authors:
DEJONG MD
BOUCHER CAB
DANNER SA
GAZZARD B
GRIFFITHS PD
KATLAMA C
LANGE JMA
RICHMAN DD
VELLA S
Citation: Md. Dejong et al., SUMMARY OF THE INTERNATIONAL CONSENSUS SYMPOSIUM ON MANAGEMENT OF HIV, CMV AND HEPATITIS-VIRUS INFECTIONS, Antiviral research, 37(1), 1998, pp. 1-16
Citation: B. Gazzard, 1998 REVISION TO THE BRITISH HIV ASSOCIATION GUIDELINES FOR ANTIRETROVIRAL TREATMENT OF HIV-SEROPOSITIVE INDIVIDUALS (VOL 352, PG 314, 1998), Lancet, 352(9137), 1998, pp. 1394-1394
Citation: B. Gazzard et G. Moyle, 1998 REVISION TO THE BRITISH HIV ASSOCIATION GUIDELINES FOR ANTIRETROVIRAL TREATMENT OF HIV-SEROPOSITIVE INDIVIDUALS, Lancet, 352(9124), 1998, pp. 314-316
Citation: P. Neild et al., BILIARY MANOMETRY IN AIDS-RELATED CHOLANGITIS (ARC) - RELATIONSHIP TOSYMPTOMS AND RADIOLOGICAL FINDINGS, Gastroenterology, 114(4), 1998, pp. 2181-2181
Authors:
NEILD P
KUMAR M
HANNAN M
AZADIAN B
GAZZARD B
Citation: P. Neild et al., HELICOBACTER SPECIES ISOLATED FROM STOOL SPECIMENS IN HIV-SEROPOSITIVE (HIV+VE) PATIENTS WITH DIARRHEA WERE NOT DETECTED BY CONVENTIONAL MICROBIOLOGICAL TECHNIQUES, Gastroenterology, 114(4), 1998, pp. 4296-4296
Authors:
ROWBOTTOM AW
LEPPER MW
SHARPSTONE D
GAZZARD B
Citation: Aw. Rowbottom et al., CYTOMEGALOVIRUS (CMV) INFECTION IN AIDS PATIENTS IS ASSOCIATED WITH ACD3 RECEPTOR-MEDIATED T-CELL HYPORESPONSIVENESS, Clinical and experimental immunology, 111(3), 1998, pp. 559-563
Authors:
MOCROFT A
YOULE M
PHILLIPS AN
HALAI R
EASTERBROOK P
JOHNSON MA
GAZZARD B
Citation: A. Mocroft et al., THE INCIDENCE OF AIDS-DEFINING ILLNESSES IN 4883 PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, Archives of internal medicine, 158(5), 1998, pp. 491-497
Authors:
MOCROFT A
YOULE M
MORCINEK J
SABIN CA
GAZZARD B
JOHNSON MA
PHILLIPS AN
Citation: A. Mocroft et al., SURVIVAL AFTER DIAGNOSIS OF AIDS - A PROSPECTIVE OBSERVATIONAL STUDY OF 2625 PATIENTS, BMJ. British medical journal, 314(7078), 1997, pp. 409-413
Authors:
SHARPSTONE D
ROSS H
HANCOCK M
PHELAN M
CRANE R
GAZZARD B
Citation: D. Sharpstone et al., INDIRECT CALORIMETRY, BODY-COMPOSITION AND SMALL BOWEL-FUNCTION IN ASYMPTOMATIC HIV-SEROPOSITIVE WOMEN, International journal of STD & AIDS, 8(11), 1997, pp. 700-703
Authors:
MARRIOTT JB
COOKSON S
CARLIN E
YOULE M
HAWKINS DA
NELSON M
PEARSON P
VAUGHAN AN
GAZZARD B
DALGLEISH AG
Citation: Jb. Marriott et al., A DOUBLE-BLIND PLACEBO-CONTROLLED PHASE-II TRIAL OF THALIDOMIDE IN ASYMPTOMATIC HIV-POSITIVE PATIENTS - CLINICAL TOLERANCE AND EFFECT ON ACTIVATION MARKERS AND CYTOKINES, AIDS research and human retroviruses, 13(18), 1997, pp. 1625-1631
Authors:
DEJONG MD
BOUCHER CAB
COOPER DA
GALASSO GJ
GAZZARD B
LANGE JMA
MONTANER JS
RICHMAN DD
THOMAS HC
Citation: Md. Dejong et al., SUMMARY OF THE 2ND INTERNATIONAL CONSENSUS SYMPOSIUM ON COMBINED ANTIVIRAL THERAPY AND IMPLICATIONS FOR FUTURE THERAPIES, Antiviral research, 35(2), 1997, pp. 65-82
Authors:
BRUNVEZINET F
BOUCHER C
LOVEDAY C
DESCAMPS D
FAUVEAU V
IZOPET J
JEFFRIES D
KAYE S
KRZYANOWSKI C
NUNN A
SCHUURMAN R
SEIGNEURIN JM
TAMALET C
TEDDER R
WEBER J
WEVERLING GJ
ABER V
ABOULKER JP
BABIKER AG
BRAGMAN K
BRECKENRIDGE AM
CARBON C
CHARREAU I
CHENE G
COLLIS P
COOPER D
DARBYSHIRE JH
DORMONT J
FIDDIAN P
FLEPP M
GAZZARD B
GOEBEL FD
HOOKER M
LANGE J
LUTHY R
PETO TEA
REISS P
SELIGMANN M
STONE AB
THOMIS J
VELLA S
WALCKENAER G
WARRELL D
WELLER IVD
WILBER R
YENI P
YEO J
WITHNALL R
BABIKER A
BLOCH J
POUCHER C
DARBYSHIRE J
GOUDSMIT J
HURAUX JM
VANDERNOORDAA J
WEISS R
WEVERLING G
Citation: F. Brunvezinet et al., HIV-1 VIRAL LOAD, PHENOTYPE, AND RESISTANCE IN A SUBSET OF DRUG-NAIVEPARTICIPANTS FROM THE DELTA-TRIAL, Lancet, 350(9083), 1997, pp. 983-990
Authors:
COOPER DA
KATLAMA C
MONTANER J
COLLIS PJ
ANTUNES F
ATKINSON M
CLARK A
CLUMECK N
COLLIS P
GAZZARD B
GERSTOFT J
GOH L
HILL A
KORSIA S
LANGE J
MCCALLUM L
MCDADE H
MALLOLAS J
MORONI M
NORKRANS G
OPRAVIL M
REISS P
ROZENBAUM W
SCOTT J
SMITH D
STASZEWSKI S
STOFFELS P
Citation: Da. Cooper et al., RANDOMIZED TRIAL OF ADDITION OF LAMIVUDINE OR LAMIVUDINE PLUS LOVIRIDE TO ZIDOVUDINE-CONTAINING REGIMENS FOR PATIENTS WITH HIV-1 INFECTION - THE CAESAR TRIAL, Lancet, 349(9063), 1997, pp. 1413-1421
Authors:
HANCOCK MR
SMITH NA
HAWKINS DA
GAZZARD B
BALL SG
Citation: Mr. Hancock et al., BIOCHEMICAL ASSESSMENT OF PANCREATIC DISEASE IN HUMAN-IMMUNODEFICIENCY-VIRUS INFECTED MEN, Journal of Clinical Pathology, 50(8), 1997, pp. 674-676
Authors:
SHARPSTONE D
ROWBOTTOM A
FRANCIS N
TOVEY G
ELLIS D
BARRETT M
GAZZARD B
Citation: D. Sharpstone et al., THALIDOMINE - A NOVEL THERAPY FOR MICROSPORIDIOSIS (VOL 112, PG 1823,1997), Gastroenterology, 113(3), 1997, pp. 1054-1054
Citation: La. Fearfield et al., AQUAGENIC URTICARIA AND HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - TREATMENT WITH STANOZOLOL, British journal of dermatology, 137(4), 1997, pp. 620-622